Compare INO to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 1.20 |
|---|---|
| Trade Time: | Dec 24 |
| Change: | 0.00 (0.00%) |
| Prev Close: | 1.20 |
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 4.00 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 0.18 - 3.40 |
| Volume: | 0 |
| Avg Vol (3m): | 913,920 |
| Market Cap: | 122.55M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.34 |
| Div & Yield: | N/A (N/A) |
| Mon, Dec 21 | Inovio Biomedical Appoints Electroporation Delivery Expert Dr. Iacob Mathiesen to Its Scientific Advisory BoardBusiness Wire |
| Mon, Nov 30 | Inovio Biomedical’s hepatitis C vaccine progressesat bizjournals.com |
| Mon, Nov 30 | Inovio Partner Announces Completion of Phase I DNA Vaccine StudyBusiness Wire |
| Fri, Nov 20 | Biotech Stocks: Inovio, Merck gain; Novavax fallsat MarketWatch |
| Fri, Nov 20 | DryShips, Synovus: Late Volume Playsat TheStreet.com |
| Fri, Nov 20 | NYSSA Presents 13th Annual Biotech and Specialty Pharmaceuticals ConferenceBusiness Wire |
| Fri, Nov 20 | Biotech Stocks: Inovio soars, Novavax falls in early actionat MarketWatch |
| Fri, Nov 20 | Inovio Biomedical Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical StudiesBusiness Wire |
| Thu, Nov 19 | INOVIO BIOMEDICAL CORP Files SEC form 8-K/A, Change in Directors or Principal OfficersEDGAR Online |
| Thu, Nov 19 | INOVIO BIOMEDICAL CORP FinancialsEDGAR Online Financials |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.